These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22202345)

  • 1. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer].
    Kuwabara H; Baba H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2250-2. PubMed ID: 22202345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy].
    Tanaka K; Hirai K; Ogawa H; Toya H; Totsuka O; Yoshinari D; Sunose Y; Takeyoshi I
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):993-5. PubMed ID: 22705700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
    de Melo JV; Vieira de Melo MS; Abad MH
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
    Hoshino H; Ishii Y; Hasegawa H; Endo T; Ochiai H; Hoshino Y; Matsunaga A; Shigeta K; Seo Y; Hoshino G; Kitagawa Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):983-6. PubMed ID: 22705698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ovarian metastasis after complete response of colon cancer].
    Nishimura T; Maeda Y; Okada T; Nakamura M; Sakata K; Setoguchi M; Kawasaki N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2263-5. PubMed ID: 20037390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bevacizumab in combination with mFOLFOX6 or FOLFIRI for previously treated metastatic colorectal cancer].
    Koyama M; Murata A; Kimura Y; Sakamoto Y; Morohashi H; Kimura N; Gasa F; Sato J; Terui K; Awatsu A; Hakamada K
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1069-73. PubMed ID: 20567110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of sigmoid colon cancer with peritoneal dissemination responding to third-line therapy employing bevacizumab combination therapy after failure of FOLFOX and FOLFIRI].
    Tamura T; Ishikawa N; Koui S; Nakashima H; Minagawa N; Hachiya Y; Hirata K; Sako T; Fukuyama T; Hirano Y
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1813-6. PubMed ID: 20841954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
    Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of chemotherapy plus bevacizumab as second-line therapy for patients with metastatic colorectal cancer that progressed on bevacizumab with chemotherapy: the Gunma Clinical Oncology Group (GCOG) trial 001 SILK study.
    Tsutsumi S; Ishibashi K; Uchida N; Ojima H; Hosouchi Y; Yashuda N; Kigure W; Yamauchi S; Asao T; Ishida H; Kuwano H
    Oncology; 2012; 83(3):151-7. PubMed ID: 22889925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Third-line therapy in a patient with recurrent colon cancer undergoing hemodialysis].
    Matsuda M; Seyama Y; Inada K; Miyata Y; Shida D; Maeshiro T; Miyamoto S; Umekita N
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1397-400. PubMed ID: 24196079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of bevacizumab for advanced colorectal cancer].
    Naito M; Hoshino S; Noda N; Nakano M; Matsuo K; Yamauchi Y; Shinohara T; Tanaka S; Yamashita Y
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):83-8. PubMed ID: 20087037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Ascending Colon Cancer Showing Marked Reduction of Ascites by Bevacizumab Combination Chemotherapy].
    Kusama T; Higashida A; Komatsubara T; Nishigori H; Kokado Y; Ishii M
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1119-21. PubMed ID: 26469173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].
    Yoshida Y; Hasegawa J; Nishimura J; Hirota M; Kim Y; Nezu R
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1293-6. PubMed ID: 21829066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical efficacy of FOLFIRI and bevacizumab in combination as first-line therapy of metastatic colorectal cancer.
    Grothey E; Chu E
    Clin Colorectal Cancer; 2007 Sep; 6(9):621-4. PubMed ID: 17945033
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of drug-induced lung injury associated with chemotherapy (FOLFOX6, FOLFIRI, Bevacizumab) for an advanced colon cancer].
    Komaki C; Hanatate F; Kobayashi K
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):113-6. PubMed ID: 21368470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).
    Sawai K; Goi T; Koneri K; Katayama K; Yamaguchi A
    World J Surg Oncol; 2013 Aug; 11(1):203. PubMed ID: 23957924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term survival of a patient with advanced colon cancer and para-aortic lymph node metastases treated with re-administration of high-dose molecular targeted agent bevacizumab].
    Ebisawa Y; Chisato N; Okayama T; Tani C; Kono T; Taniguchi M; Furukawa H
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1401-4. PubMed ID: 24196080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report].
    Tagami Y; Ogata S; Katakawa M; Bando Y
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):317-9. PubMed ID: 22333652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential or combination chemotherapy for a patient with mCRC?
    Arnold D
    Cancer Treat Rev; 2008; 34 Suppl 2():S12-6. PubMed ID: 19101403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of liver metastases from rectal cancer showed a complete response by FOLFIRI and bevacizumab chemotherapy].
    Kuwada A; Nakamitsu A; Imamura Y; Kouyama M; Uekami S; Touge K; Taogoshi H; Fukuda Y; Daimaru H
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2937-40. PubMed ID: 21160275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.